References
- Heiser J. F., Wilbert D. E. Reversal of delirium induced by tricyclic antidepressant drugs with physostigmine. Am., J. Psychiat. 1971; 128: 127
- Granacher R. P., Baldessarini R. J. Physostigmine, its use in acute anticholinergic syndrome with antidepressant and antiparkinson drugs. Arch. Gen. Psychiat. 1975; 32: 375
- Delay J., Deniker P. Efficiency of Tofranil in the treatment of various types of depression. Can. Psychiat. Assoc. J. 1959; 4: 100, (Suppl. 4)
- Williams R. B., Sheiter C. Cardiac complications of tricyclic antidepressant therapy. Ann. Intern. Med. 1971; 74: 395
- Raisfeld I. D. Cardiovascular complications of antidepressant therapy. Am. Heart J. 1972; 83: 129
- Stille G., Hippius H. Kritische Stellungnahme zum Begriff der Neuroleptika. Pharmacopsychiat. 1971; 4: 182
- Gross H., Langner E. Das Wirkungsprofil eines chemisch neuartigen Breitbandneuroleptikums der Dibenzoazepingruppe. Wien. Med. Wosch. 1966; 116: 814
- Angst J., Jaenicke U., Padrutt A., Scharfetter Ch. Ergebnisse eines Doppelblindversuches von HF 1854 (8-Chlor-11- (4-methyl- 1-piperazinyl)-5H-dibenzo (b, e) (1, 4) diazepin im Vergleich zu Levomeprazin. Pharmakopsychiat. 1971; 4: 192
- Athen D., Meyer G. Clozapin bei psychomotorischen Erregungszuständen. Therapiewoche 1975; 18: 2491
- Snyder S., Greenberg D., Yamamura H. I. Antischizophrenic drugs and brain cholinergic receptors. Arch. Gen. Phychiat. 1974; 31: 58
- Miller R. J., Hiley C. R. Antimuscarinic properties of neuroleptics and drug-induced Parkinsonism. Nature 1974; 248: 596
- Sayers A. C., Bürki H. R., Ruch W., Asper H. Neurolepticinduced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazine. Psychopharmacol. 1975; 41: 97